Cited by 2,089Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health EffectsLiver physiology and pathology

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Human Fatty Liver Disease: Old Questions and New Insights

Open access

Cohen, Jonathan C., Horton, Jay D., Hobbs, Helen H.·2011·Science

DOI 10.1126/science.1204265PMC PMC3229276

Open this paper in CoChat — free account

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem that affects one-third of adults and an increasing number of children in developed countries. The disease begins with the aberrant accumulation of triglyceride in the liver, which in some individuals elicits an inflammatory response that can progress to cirrhosis and liver cancer. Although NAFLD is strongly associated with obesity and insulin resistance, its pathogenesis remains poorly understood, and therapeutic options are limited. Here, we discuss recent mechanistic insights into NAFLD, focusing primarily on those that have emerged from human genetic and metabolic studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/science.1204265

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Self-citation
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citation
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Self-citation
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Self-citation
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802
Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase
Zimmermann, R., Bogner‐Strauß, J. G., Haemmerle, G., Schoiswohl, G., Birner‐Gruenberger, R., Riederer, M., Lass, A., Neuberger, G., Eisenhaber, F., Hermetter, A., et al. (2004) · Science · doi:10.1126/science.1100747 · Cited by 2,121
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
Szczepaniak, L. S., Nurenberg, P., Leonard, D. S., Browning, J. D., Reingold, J. S., Grundy, S. M., Hobbs, H. H., & Dobbins, R. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,573
Self-citation
Prevalence of Fatty Liver in Children and Adolescents
Schwimmer, J. B., Deutsch, R., Kahen, T., Lavine, J. E., Stanley, C. R., & Behling, C. A. (2006) · PEDIATRICS · doi:10.1542/peds.2006-1212 · Cited by 1,477

Flagged first, then by citations

Show all 53 references

1 of the 53 references couldn’t be matched to a known paper.

Sorted by citations

Items 901–1,000 of 1,007

Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease
Liu, W., Zheng, K. I., Pan, X., Ma, H., Zhu, P., Wu, X., Rios, R. S., Targher, G., Byrne, C. D., Wang, X., et al. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14894 · Cited by 33
Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis
Kozlitina, J. (2020) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.09.001 · Cited by 33
Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high‐fat diet in the genetically diverse Collaborative Cross mouse model
de Conti, A., Tryndyak, V., Willett, R. A., Borowa‐Mazgaj, B., Watson, A., Patton, R. E., Khare, S., Muskhelishvili, L., Olson, G. R., Avigan, M., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000194r · Cited by 33
Functional Metabolomics Reveals that Astragalus Polysaccharides Improve Lipids Metabolism through Microbial Metabolite 2-Hydroxybutyric Acid in Obese Mice
Li, B., Hong, Y., Gu, Y., Ye, S., Hu, K., Yao, J., Ding, K., Zhao, A., Jia, W. P., & Li, H. (2020) · Engineering · doi:10.1016/j.eng.2020.05.023 · Cited by 33
Improved Folch Method for Liver-Fat Quantification
Mopuri, R., Kalyesubula, M., Rosov, A., Edery, N., Moallem, U., & Dvir, H. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.594853 · Cited by 35
Blueberry as an Attractive Functional Fruit to Prevent (Pre)Diabetes Progression
Nunes, S., Vieira, P., Gomes, P., Viana, S., & Reis, F. (2021) · Antioxidants · doi:10.3390/antiox10081162 · Cited by 33
Visualization of peroxynitrite in cyclophosphamide-induced oxidative stress by an activatable probe
Li, J., Peng, S., Li, Z., Zhao, F., Han, X., Liu, J., Cao, W., & Ye, Y. (2021) · Talanta · doi:10.1016/j.talanta.2021.123007 · Cited by 34
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease
Olveira, A., Augustín, S., Benlloch, S., Ampuero, J., Suárez‐Pérez, J. A., Armesto, S., Vilarrasa, E., Belinchón, I., Herranz, P., Crespo, J., et al. (2023) · Life · doi:10.3390/life13020419 · Cited by 38
‘Micro‐managers’ of hepatic lipid metabolism and NAFLD
Liu, W., Cao, H., Yan, J., Huang, R., & Ying, H. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1295 · Cited by 33
Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis
Santoro, N., Caprio, S., & Feldstein, A. E. (2013) · Clinical Lipidology · doi:10.2217/clp.13.39 · Cited by 33
Role of glucose-6-phosphate and xylulose-5-phosphate in the regulation of glucose-stimulated gene expression in the pancreatic β cell line, INS-1E
Iizuka, K., Wu, W., Horikawa, Y., & Takeda, J. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0413 · Cited by 33
Molecular mechanisms of fatty liver in obesity
Gan, L., Xiang, W., Xie, B., & Yu, L. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0410-2 · Cited by 37
Mogat1 deletion does not ameliorate hepatic steatosis in lipodystrophic (Agpat2−/−) or obese (ob/ob) mice
Agarwal, A. K., Tunison, K., Dalal, J. S., Yen, C. E., Farese, R. V., Horton, J. D., & Garg, A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m065896 · Cited by 33
Self-citation
Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms
Nelson, J. E., Handa, P., Aouizerat, B. E., Wilson, L., Vemulakonda, L. A., Yeh, M. M., & Kowdley, K. V. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13824 · Cited by 33
SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease
Mazzolini, G. D., Atorrasagasti, C., Onorato, A. M., Peixoto, E., Schlattjan, M., Sowa, J., Sydor, S., Gerken, G., & Canbay, A. E. (2018) · Scientific Reports · doi:10.1038/s41598-017-18981-9 · Cited by 33
Lipids in Liver Disease: Looking Beyond Steatosis
Schwabe, R. F., & Maher, J. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.11.004 · Cited by 33
Dietary cholesterol induces hepatic inflammation and blunts mitochondrial function in the liver of high-fat-fed mice
Li, S., Zeng, X., Zhou, X., Wang, H., Jo, E., Robinson, S. R., Xu, A., & Ye, J. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.021 · Cited by 32
Carbohydrate Quality and Quantity Affect Glucose and Lipid Metabolism during Weight Regain in Healthy Men
Lagerpusch, M., Enderle, J., Eggeling, B., Braun, W., Johannsen, M., Pape, D., Müller, M. J., & Bosy‐Westphal, A. (2013) · Journal of Nutrition · doi:10.3945/jn.113.179390 · Cited by 32
Lipid accumulation stimulates the cap-independent translation of SREBP-1a mRNA by promoting hnRNP A1 binding to its 5′-UTR in a cellular model of hepatic steatosis
Siculella, L., Tocci, R., Rochira, A., Testini, M., Gnoni, A., & Damiano, F. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.02.003 · Cited by 32
Comparative Proteomic Study of Fatty Acid-treated Myoblasts Reveals Role of Cox-2 in Palmitate-induced Insulin Resistance
Chen, X., Xu, S., Wei, S., Deng, Y., Li, Y., Yang, F., & Liu, P. (2016) · Scientific Reports · doi:10.1038/srep21454 · Cited by 32
Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2
Piacentini, M., Baiocchini, A., Nonno, F. D., Melino, G., Barlev, N. A., Rossin, F., D’Eletto, M., & Falasca, L. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0292-8 · Cited by 32
Interleukin‐4 Boosts Insulin‐Induced Energy Deposits by Enhancing Glucose Uptake and Lipogenesis in Hepatocytes
Yang, C., Shiau, M., Lai, Y.-R., Ho, K.-T., Hsiao, C., Chen, C., Lo, Y., & Chang, Y.-H. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6923187 · Cited by 32
From Liver Fat to Cancer: Perils of the Western Diet
Kim, J. Y., He, F., & Karin, M. (2021) · Cancers · doi:10.3390/cancers13051095 · Cited by 32
Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease
Pan, M., Zheng, C., Deng, Y., Tang, K., Nie, H., Xie, J., Liu, D., Tu, G.-F., Yang, Q.-H., & Zhang, Y. (2021) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2021.07.004 · Cited by 32
Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes
Hu, X., Zhou, R., Li, H., Zhao, X., Sun, Y., Fan, Y., & Zhang, S. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.805812 · Cited by 32
Homeostatic generation of reactive oxygen species protects the zebrafish liver from steatosis
Nussbaum, J. M., Liu, L. J., Hasan, S. A., Schaub, M., McClendon, A., Stainier, D. Y. R., & Sakaguchi, T. F. (2013) · Hepatology · doi:10.1002/hep.26551 · Cited by 31
Obesity-related cardiorenal disease: the benefits of bariatric surgery
Fenske, W., Athanasiou, T., Harling, L., Drechsler, C., Darzi, A. W., & Ashrafian, H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.145 · Cited by 32
ω-3 Fatty acids reverse lipotoxity through induction of autophagy in nonalcoholic fatty liver disease
Chen, Y., Xu, C., Yan, T., Yu, C., & Li, Y. (2015) · Nutrition · doi:10.1016/j.nut.2015.05.022 · Cited by 32
Differential Effect of Troglitazone on the Human Bile Acid Transporters, MRP2 and BSEP, in the PXB Hepatic Chimeric Mouse
Foster, J. R., Jacobsen, M. C., Kenna, J. G., Schulz-Utermoehl, T., Morikawa, Y., Salmu, J., & Wilson, I. D. (2012) · Toxicologic Pathology · doi:10.1177/0192623312447542 · Cited by 32
Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line
Green, C., Johnson, D., Amin, H. D., Sivathondan, P., Silva, M. A., Wang, L. M., Stevanato, L., McNeil, C. A., Miljan, E., Sinden, J. D., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00594.2014 · Cited by 32
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model
Tessitore, A., Mastroiaco, V., Vetuschi, A., Sferra, R., Pompili, S., Cicciarelli, G., Barnabei, R., Capece, D., Zazzeroni, F., Capalbo, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18585 · Cited by 32
Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha
Li, G., Brocker, C. N., Yan, T., Xie, C., Krausz, K. W., Xiang, R., & Gonzalez, F. J. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.10.011 · Cited by 32
Liver Disease Prediction and Classification using Machine Learning Techniques
Tokala, S., Hajarathaiah, K., Gunda, S. R. P., Botla, S., Nalluri, L., Nagamanohar, P., Anamalamudi, S., & Enduri, M. K. (2023) · International Journal of Advanced Computer Science and Applications · doi:10.14569/ijacsa.2023.0140299 · Cited by 31
Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways
Stachowicz, A., Czepiel, K., Wiśniewska, A., Stachyra, K., Ulatowska-Białas, M., Kuśnierz‐Cabala, B., Surmiak, M., Majka, G., Kuś, K., Wood, M. E., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107428 · Cited by 32
Fenofibrate Treatment Attenuated Chronic Endoplasmic Reticulum Stress in the Liver of Nonalcoholic Fatty Liver Disease Mice
Zhang, N., Lu, Y., Shen, X., Bao, Y., Cheng, J., Chen, L., Bao, L., & Zhang, Q. (2015) · Pharmacology · doi:10.1159/000380952 · Cited by 31
Livers with Constitutive mTORC1 Activity Resist Steatosis Independent of Feedback Suppression of Akt
Kenerson, H. L., Subramanian, S., McIntyre, R. L., Kazami, M., & Yeung, R. S. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117000 · Cited by 30
Comparative proteomic analysis using 2DE‐LC‐MS/MS reveals the mechanism of Fuzhuan brick tea extract against hepatic fat accumulation in rats with nonalcoholic fatty liver disease
Liu, Z., Lin, Y., Zhang, S., Wang, D., Liang, Q., & Luo, G. (2015) · Electrophoresis · doi:10.1002/elps.201500076 · Cited by 32
Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases
Xia, M., Bian, H., Yan, H., Lin, H., Chang, X., Li, X., Ma, H., He, W., Zhao, N., Xia, P., et al. (2015) · Obesity · doi:10.1002/oby.21182 · Cited by 31
Siphonaxanthin, a Carotenoid From Green Algae, Inhibits Lipogenesis in Hepatocytes via the Suppression of Liver X Receptor α Activity
Zheng, J., Li, Z., Manabe, Y., Kim, M., Goto, T., Kawada, T., & Sugawara, T. (2018) · Lipids · doi:10.1002/lipd.12002 · Cited by 31
MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1
Gong, R., Lv, X., & Liu, F. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0083-3 · Cited by 31
A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis
Kawaguchi‐Suzuki, M., Cusi, K. J., Bril, F., Gong, Y., Langaee, T. Y., & Frye, R. F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00752 · Cited by 31
Prenatal exposure to diesel exhaust PM2.5 programmed non-alcoholic fatty liver disease differently in adult male offspring of mice fed normal chow and a high-fat diet.
Wang, X.-K., Yang, Y.-X., Zhu, P., Wu, Y., Jin, Y., Yu, S., Wei, H.-Y., Qian, M., Cao, W., Xu, S., et al. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113366 · Cited by 26
Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease
Zhang, H., Yang, L., Wang, Y., Huang, W., Yang, L., Chen, S., Song, G., & Ren, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118090 · Cited by 31
The Protective Effect of Myristica fragrans Houtt. Extracts Against Obesity and Inflammation by Regulating Free Fatty Acids Metabolism in Nonalcoholic Fatty Liver Disease
Zhao, W., Song, F., Hu, D., Chen, H., Zhai, Q., Lu, W., Zhao, J., Zhang, H., Chen, W., Gu, Z., et al. (2020) · Nutrients · doi:10.3390/nu12092507 · Cited by 31
Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2
Ma, C., Wang, Z., Xia, R., Wei, L., Zhang, C., Zhang, J., Zhao, L., Wu, H., Kang, L., & Yang, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111344 · Cited by 31
Canagliflozin Attenuates Hepatic Steatosis and Atherosclerosis Progression in Western Diet-Fed ApoE-Knockout Mice
Zuo, Q., Zhang, G., He, L., Ma, S., Ma, H., Zhai, J., Wang, Z., Zhang, T., Wang, Y., & Guo, Y. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s388823 · Cited by 31
Low‐fasting triglyceride levels are associated with non‐invasive markers of advanced liver fibrosis among adults in the United States
Jiang, Z. G., Tsugawa, Y., Tapper, E. B., Lai, M., Afdhal, N. H., Robson, S. C., & Mukamal, K. J. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13216 · Cited by 31
MicroRNA changes, activation of progenitor cells and severity of liver injury in mice induced by choline and folate deficiency
Tryndyak, V., Marrone, A. K., Latendresse, J. R., Muskhelishvili, L., Beland, F. A., & Pogribny, I. P. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.10.001 · Cited by 31
Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases
Zhang, Y., & Li, H. (2017) · Physiology · doi:10.1152/physiol.00038.2016 · Cited by 32
Podocyte-specific knockin of PTEN protects kidney from hyperglycemia
Wang, H., Feng, Z., Xie, J., Wen, F., Jv, M., Liang, T., Li, J., Wang, Y., Zuo, Y., Li, S., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00575.2017 · Cited by 28
Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023)
Dai, J.-J., Zhang, Y., & Zhang, Z. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i37.5339 · Cited by 31
The Sympathetic‐Immune Milieu in Metabolic Health and Diseases: Insights from Pancreas, Liver, Intestine, and Adipose Tissues
Ren, W., Hua, M., Cao, F., & Zeng, W. (2023) · Advanced Science · doi:10.1002/advs.202306128 · Cited by 32
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum
Vidal‐Cevallos, P., Sorroza-Martínez, A. P., Chávez-Tapia, N. C., Uribe, M., Montalvo-Jave, E. E., & Nuño‐Lámbarri, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084397 · Cited by 32
Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases.
McCully, K. S. (2011) · PubMed · Cited by 29
A Metabonomics Approach to Drug Toxicology in Liver Disease and its Application in Traditional Chinese Medicine
Su, G., Wang, H., Bai, J., Chen, G., & Pei, Y. (2019) · Current Drug Metabolism · doi:10.2174/1389200220666181231124439 · Cited by 30
The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China
Tan, Y., Zhang, X., Zhang, W., Tang, L., Yang, H., Yan, K., Jiang, L., Yang, J., Li, C., Yang, J., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0303 · Cited by 30
GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress
Kim, H. J., Lee, Y., Fang, S., Kim, W. K., Kim, H. J., & Kim, J. W. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.6.280 · Cited by 30
GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non‐alcoholic fatty liver disease via microRNA‐200 and the MAPK pathway
Wang, Y., Zeng, Z., Guan, L., & Ao, R. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15212 · Cited by 30
The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease
Seo, J.-Y., Bae, J.-H., Kwak, M., Yang, J. I., Chung, S.-J., Yim, J.-Y., Lim, S.-H., & Chung, G. E. (2021) · Biomedicines · doi:10.3390/biomedicines9101401 · Cited by 30
S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis
Liu, X., Wang, Y., Ming, Y., Song, Y., Zhang, J., Chen, X., Zeng, M., & Mao, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127352 · Cited by 30
Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes
Li, N., Tan, H., Xie, A., Li, C., Fu, X., Xang, W., Kirim, A., & Huang, X. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00993-w · Cited by 30
Discovery of Ervogastat (PF-06865571): A Potent and Selective Inhibitor of Diacylglycerol Acyltransferase 2 for the Treatment of Non-alcoholic Steatohepatitis
Futatsugi, K., Cabral, S., Kung, D. W., Huard, K., Lee, E. C. Y., Boehm, M., Bauman, J. N., Clark, R. W., Coffey, S. B., Crowley, C., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01200 · Cited by 33
Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
Morishita, A., Oura, K., Takuma, K., Nakahara, M., Tadokoro, T., Fujita, K., Tani, J., Shi, T., Himoto, T., Tatsuta, M., et al. (2022) · Hepatology International · doi:10.1007/s12072-022-10453-1 · Cited by 30
Comparison of in vivo effects of insulin on SREBP-1c activation and INSIG-1/2 in rat liver and human and rat adipose tissue
Boden, G. H., Salehi, S., Cheung, P., Homko, C. J., Song, W., Loveland-Jones, C. E., & Jayarajan, S. N. (2013) · Obesity · doi:10.1002/oby.20134 · Cited by 32
Effects of Chaihu‐Shugan‐San and Shen‐Ling‐Bai‐Zhu‐San on p38 MAPK Pathway in Kupffer Cells of Nonalcoholic Steatohepatitis
Yang, Q., Xu, Y., Liu, Y., Liang, Y., Feng, G.-F., Zhang, Y., Xing, H., Yan, H.-Z., & Li, Y. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/671013 · Cited by 30
Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis
Passos, E., Pereira, C., Gonçalves, I. O., Rocha‐Rodrigues, S., Silva, N., Guimarães, J. T., Neves, D., Ascensão, A. A. M. R., Magalhães, J., & Martins, M. J. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.12.013 · Cited by 31
Reducing Liver Fat by Low Carbohydrate Caloric Restriction Targets Hepatic Glucose Production in Non-Diabetic Obese Adults with Non-Alcoholic Fatty Liver Disease
Yu, H., Jia, W., & Guo, Z. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3031050 · Cited by 30
Low Serum Lysosomal Acid Lipase Activity Correlates with Advanced Liver Disease
Shteyer, E., Villenchik, R., Mahamid, M., Nator, N., & Safadi, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030312 · Cited by 30
Status of hepatic DNA methylome predetermines and modulates the severity of non-alcoholic fatty liver injury in mice
Tryndyak, V., Han, T., Fuscoe, J. C., Ross, S. A., Beland, F. A., & Pogribny, I. P. (2016) · BMC Genomics · doi:10.1186/s12864-016-2617-2 · Cited by 30
Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects
YANG, Z. K., Zhang, H., Niu, Y., Zhang, W., Zhu, L., Li, X., Lü, S., Fan, J., Li, X., Ning, G., et al. (2016) · Scientific Reports · doi:10.1038/srep37886 · Cited by 30
Crucial Roles of 5-HT and 5-HT2 Receptor in Diabetes-Related Lipid Accumulation and Pro-Inflammatory Cytokine Generation in Hepatocytes
Fu, J., Li, C., Zhang, G., Tong, X., Zhang, H., Ding, J., Ma, Y., Cheng, R., Hou, S., An, S., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492656 · Cited by 31
A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male Ldlr -/- Mice
García‐Jaramillo, M., Lytle, K. A., Spooner, M. H., & Jump, D. Β. (2019) · Metabolites · doi:10.3390/metabo9110252 · Cited by 31
TUBB2B facilitates progression of hepatocellular carcinoma by regulating cholesterol metabolism through targeting HNF4A/CYP27A1
Wang, X., Shi, J., Huang, M., Chen, J., Dan, J., Tang, Y., Guo, Z., He, X., & Zhao, Q. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05687-2 · Cited by 29
Betulin prevents high fat diet-induced non-alcoholic fatty liver disease by mitigating oxidative stress and upregulating Nrf2 and SIRT1 in rats
Farage, A. E., Abdo, W. S., Osman, A., Abdel‐Kareem, M. A., Hakami, Z. H., Alsulimani, A., Bin‐Ammar, A., Alanazi, A. S., Alsuwayt, B., Alanazi, M. M., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121688 · Cited by 29
Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders
Sun, K., Lu, J., Jiang, Y., Xu, M., Xu, Y., Zhang, J., Xu, B., Sun, J., Sun, W., Ren, C., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12168 · Cited by 29
Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice
Sugamori, K. S., Brenneman, D., Sanchez, O. H., Doll, M. A., Hein, D. W., Pierce, W. M. J., & Grant, D. M. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.12.022 · Cited by 29
Nonalcoholic fatty liver disease: Updates in noninvasive diagnosis and correlation with cardiovascular disease
Hu, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7718 · Cited by 29
Dietary fat source alters hepatic gene expression profile and determines the type of liver pathology in rats overfed via total enteral nutrition
Ronis, M. J. J., Baumgardner, J. N., Marecki, J. C., Hennings, L. J., Wu, X., Shankar, K., Cleves, M. A., Gómez-Acevedo, H., & Badger, T. M. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00069.2012 · Cited by 29
TAK1 regulates hepatic lipid homeostasis through SREBP
Morioka, S., Sai, K., Omori, E., Ikeda, Y., Matsumoto, K., & Ninomiya‐Tsuji, J. (2016) · Oncogene · doi:10.1038/onc.2015.453 · Cited by 31
The whole transcriptional profiling of cellular metabolism during adipogenesis from hMSCs
Yi, X., Liu, J., Wu, P., Gong, Y., Xu, X., & Li, W. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28974 · Cited by 29
The phosphatidylserine flippase β-subunit Tmem30a is essential for normal insulin maturation and secretion
Yang, Y., Sun, K., Liu, W., Li, X., Tian, W., Shuai, P., & Zhu, X. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.026 · Cited by 29
Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea
Chung, G. E., Cho, E. J., Yoo, J., Chang, Y. W., Cho, Y., Park, S. H., Shin, D. W., Han, K., & Yu, S. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-92703-0 · Cited by 29
Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization
Chen, C., Gu, L., Matye, D. J., Clayton, Y., Hasan, M. N., Wang, Y., Friedman, J. E., & Li, T. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111737119 · Cited by 29
Alternating Dual-Collision Energy Scanning Mass Spectrometry Approach: Discovery of Novel Microbial Bile-Acid Conjugates
Zhu, Q., Wang, Y., An, N., Hao, J.-D., Mei, P.-C., Bai, Y., Hu, Y., Bai, P.-R., & Feng, Y. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c05272 · Cited by 29
In Vitro Hepatoprotective and Human Gut Microbiota Modulation of Polysaccharide-Peptides in Pleurotus citrinopileatus
Huang, Y., Gao, Y., Pi, X., Zhao, S. Z., & Liu, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.892049 · Cited by 29
Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients
Tai, C., Huang, C., Tu, H., Hwang, J., Yeh, M., Huang, C., Huang, J., Dai, C., Chuang, W., & Yu, M. (2016) · Medicine · doi:10.1097/md.0000000000003120 · Cited by 29
Associations between sitting time and non-alcoholic fatty liver diseases in Chinese male workers: a cross-sectional study
Wei, H., Qu, H., Wang, H., & Deng, H. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011939 · Cited by 32
Inhibition of MD2‐dependent inflammation attenuates the progression of non‐alcoholic fatty liver disease
Zhang, Y., Wu, B., Zhang, H., Ge, X., Ying, S., Hu, M., Li, W., Huang, Y., Wang, L., Chen, C., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13395 · Cited by 29
The role of gut microbiota in intestinal and liver diseases
Hrncir, T., Hrncirova, L., Kverka, M., & Tlaskalová‐Hogenová, H. (2018) · Laboratory Animals · doi:10.1177/0023677218818605 · Cited by 29
The GPR40 Full Agonist SCO-267 Improves Liver Parameters in a Mouse Model of Nonalcoholic Fatty Liver Disease without Affecting Glucose or Body Weight
Ookawara, M., Matsuda, K., Watanabe, M., & Moritoh, Y. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000046 · Cited by 29
Vascular targets for the treatment of portal hypertension
Brusilovskaya, K., Königshofer, P., Schwabl, P., & Reiberger, T. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1693115 · Cited by 28
Association of Obstructive Sleep Apnea with Nonalcoholic Fatty Liver Disease: Evidence, Mechanism, and Treatment
Wang, L., Liu, H., Zhou, L., Zheng, P., Li, H., Zhang, H., & Liu, W. (2024) · Nature and Science of Sleep · doi:10.2147/nss.s468420 · Cited by 28
Pla2g12b and Hpn Are Genes Identified by Mouse ENU Mutagenesis That Affect HDL Cholesterol
Khan, A. A., Choi, S., Savage, H. S., Blair, R. H., Gu, T., Svenson, K. L., Churchill, G. A., Hibbs, M., & Korstanje, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043139 · Cited by 28
Higher-Order Chromatin Regulation and Differential Gene Expression in the Human Tumor Necrosis Factor/Lymphotoxin Locus in Hepatocellular Carcinoma Cells
Watanabe, T., Ishihara, K., Hirosue, A., Watanabe, S., Hino, S., Ojima, H., Kanai, Y., Sasaki, Y., & Nakao, M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06478-11 · Cited by 28
Animal Models of Liver Diseases
Takahashi, Y., & Fukusato, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00013-9 · Cited by 27
De-silencing Grb10 contributes to acute ER stress-induced steatosis in mouse liver
Luo, L., Jiang, W., Liu, H., Bu, J., Tang, P., Du, C., Xu, Z., Luo, H., Liu, B., Xiao, B., et al. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0018 · Cited by 30
Nicotinamide riboside regulates inflammation and mitochondrial markers in AML12 hepatocytes
Lee, H. J., & Yang, S. J. (2019) · Nutrition Research and Practice · doi:10.4162/nrp.2019.13.1.3 · Cited by 29
Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China
Xu, M., Li, Y., Zhang, S., Wang, X., Shen, J., & Zhang, S. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2018.10.005 · Cited by 28
MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3
Liu, X., Zhao, J., Liu, Q., Xiong, X., Zhang, Z., Jiao, Y., Li, X., Liu, B., Li, Y., & Lu, Y. (2016) · Scientific Reports · doi:10.1038/srep37170 · Cited by 25
“However, these mice are characterized by many metabolic disorders, including obesity, insulin resistance and hyperglycemia, which may contribute as confounders to hepatic TG disorders 1,28–31 .”
Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α
Yu, L., Wang, H., Han, X., Liu, H., Zhu, D., Feng, W., Wu, J., & Bi, Y. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0555 · Cited by 19

Authors: Cohen, J. C., Horton, J. D., & Hobbs, H. H.
Affiliations: The University of Texas Southwestern Medical Center (US)
Howard Hughes Medical Institute (US)
Corresponding author: Hobbs, Helen H.
ORCID: Cohen, Jonathan C.
Horton, Jay D.
Hobbs, Helen H.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2011-06-24
Volume: 332
Issue: 6037
Pages: 1519-1523
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.1204265
PMC: PMC3229276
OpenAlex: W2065612971
Cited by: 2,089
References: 53
Citations by year: 2026: 38 · 2025: 88 · 2024: 103 · 2023: 118 · 2022: 139 · 2021: 152 · 2020: 168 · 2019: 158 · 2018: 166 · 2017: 170 · 2016: 153 · 2015: 171 · 2014: 143 · 2013: 171 · 2012: 122
FWCI: 17.33
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (P01 HL-20948, P01HL020948, RL1HL092550)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK090066)
National Institute of Dental and Craniofacial Research (UL1DE019584, UL1DE109584)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: non-alcoholic fatty liver disease, hepatic triglyceride accumulation, liver inflammation, liver cirrhosis, hepatocellular carcinoma, obesity, insulin resistance, NAFLD pathogenesis, genetic susceptibility, metabolic mechanisms
MeSH terms: Animals, Dietary Fats, Disease Models, Animal, Fatty Liver, Female, Humans, Insulin Resistance, Liver, Liver Cirrhosis, Liver Neoplasms, Male, Obesity, Triglycerides, Disease Progression, Genetic Predisposition to Disease, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Human Fatty Liver Disease: Old Questions and New Insights

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks